VRML Share Price

Open 1.31 Change Price %
High 1.31 1 Day 0.02 1.55
Low 1.24 1 Week 0.05 3.97
Close 1.31 1 Month 0.22 20.18
Volume 6018 1 Year -0.22 -14.38
52 Week High 1.94
52 Week Low 0.76
VRML Important Levels
Resistance 2 1.37
Resistance 1 1.35
Pivot 1.29
Support 1 1.27
Support 2 1.25
NASDAQ USA Most Active Stocks
ASTI 0.00 0.00%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
DRYS 1.01 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
ACAS 17.99 0.39%
More..
NASDAQ USA Top Gainers Stocks
CPSL 0.10 66.67%
LOCM 0.09 50.00%
GLBS 9.70 31.79%
LTRE 2.85 29.55%
ETRM 7.96 29.22%
INFI 2.00 29.03%
QKLS 0.14 27.27%
PRKR 2.57 26.60%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
More..
NASDAQ USA Top Losers Stocks
HEAT 0.00 -100.00%
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
AMCF 0.03 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
More..

Vermillion, Inc. (NASDAQ: VRML)

VRML Technical Analysis 4
As on 20th Jan 2017 VRML Share Price closed @ 1.31 and we RECOMMEND Buy for LONG-TERM with Stoploss of 1.26 & Strong Buy for SHORT-TERM with Stoploss of 1.13 we also expect STOCK to react on Following IMPORTANT LEVELS.
VRML Target for January
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
VRML Other Details
Segment EQ
Market Capital 18049096.00
Sector Healthcare
Industry Diagnostic Substances
Offical website http://www.vermillion.com
VRML Address
VRML
Building III
Suite 100
Austin, TX 78738
United States
Phone: 512-519-0400
Fax: 512-439-6980
VRML Latest News
Is There a Catalyst Out There For Vermillion, Inc. (NASDAQ:VRML)   Prospect Journal   - 21st Jan 17
Are the Technicals Adding up for Vermillion, Inc. (NASDAQ:VRML)   Prospect Journal   - 20th Jan 17
Vermillion Reports Third Quarter 2016 Results   PR Newswire (press release)   - 11th Nov 16
ASPiRA LABS' OVA1 Technology Receives "Level B" Recommendation in the Latest ...   PR Newswire (press release)   - 10th Nov 16
Vermillion CEO to Present at Women in Bio - New York   PR Newswire (press release)   - 19th Oct 16
Vermillion and ASPiRA LABs Applaud the FDA's Position on Ovarian Cancer Screening   PR Newswire (press release)   - 09th Sep 16
Vermillion, Inc. Kicks Off Ovarian Cancer Awareness Month by Ringing the ...   PR Newswire (press release)   - 02nd Sep 16
ASPiRA LABS Expands Coverage for OVA1® in California   PR Newswire (press release)   - 03rd Aug 16
Vermillion Announces FDA Clearance of Overa®, Second Generation OVA1® Test   PR Newswire (press release)   - 21st Mar 16
Vermillion Lands America's Most Decorated Gymnast and Ovarian Cancer Survivor ...   PR Newswire (press release)   - 09th Feb 16
Interactive Technical Analysis Chart Vermillion, Inc. ( VRML NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Vermillion, Inc.
VRML Business Profile
Vermillion, Inc. is engaged in the discovery, development and commercialization of diagnostic tests that helps physicians diagnose, treat and improve outcomes for patients. The Company's tests are intended to help guide decisions regarding patient treatment, which may include decisions to refer patients to specialists, to perform additional testing, or to assist in the selection of therapy. The Company combines multiple biomarkers into a single, reportable index score. The Company concentrates its development of diagnostic tests in the fields of oncology, cardiology and women�s health, with the initial focuses on ovarian cancer.The Company's product, OVA1, addresses a clear unmet clinical need, namely the pre-surgical identification of women who are at high risk of having a malignant ovarian tumor.In addition to OVA1, the Company has development programs in other clinical aspects of ovarian cancer as well as in peripheral arterial disease.